OTTAWA,
April 29, 2016 /CNW/
- Annidis Corporation (TSX Venture: RHA)
("Annidis" or the "Corporation") announces that,
further to its press release dated March 22,
2016, in connection with the conversion of convertible
promissory notes in the principal amount of $670,000 plus all outstanding interest having
accrued thereon up to and including March 8,
2016 (the "Notes"). The Corporation has issued a
total of 9,197,382 common shares in the capital of the Corporation
("Common Shares") to Yimai Technology International
Corporation Limited ("Yimai"), an insider of the
Corporation. As a result of the conversion of the Notes, Yimai
holds 49,179,428 common shares, representing approximately 42% of
the 117,081,250 issued and outstanding common shares in the capital
of the Corporation.
In accordance with applicable Canadian securities
laws, all securities issued in connection with the conversion of
the Notes are subject to a minimum hold period of four months and
one day from the distribution date.
About Annidis Corporation
Annidis has developed and manufactures and sells
a patented imaging platform technology based on multi-spectral
imaging. The current RHA is a retinal screening technology used by
primary care professionals for early disease detection. The RHA is
complementary to diagnostic imaging technologies and supports the
timely identification, treatment and monitoring of a wide range of
vision threatening diseases.
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Certain statements in this press release are
forward looking statements and are prospective in nature, including
statements with respect to the Corporation's intended use of the
proceeds of the Notes. Forward‐looking statements are
not based on historical facts, but rather on current expectations
and projections about future events, and are therefore subject to
risks and uncertainties which could cause actual results to differ
materially from the future results expressed or implied by the
forward‐looking statements. These statements
generally can be identified by the use of
forward‐looking words such as "may", "should",
"will", "could", "intend", "estimate", "plan", "anticipate",
"expect", "believe" or "continue", or the negative thereof or
similar variations. Such statements are qualified in their entirety
by the inherent risks and uncertainties surrounding future
expectations. Such forward‐looking statements should
therefore be construed in light of such factors, and the
Corporation is not under any obligation, and expressly disclaims
any intention or obligation, to update or revise any
forward‐looking statements, whether as a result of
new information, future events or otherwise.
SOURCE Annidis Corporation